IRCT20111224008507N6招募中3 期
Clinical trial of ealuation of phage therapy with nebulizer in prevention of secondary bacterial pneumonia in admitted patients with moderate to severe COVID-19
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 4 years 至 no limit（—）
- 性别
- All
入选标准
- •Children and adults with moderate to severe COVID-19 (moderate: Evidence of pulmonary involvement or symptoms on imaging. severe: Respiratory rate more than 30 times per minute + percentage of blood oxygen saturation less than 93% + infiltration more than 50% in the lungs)
- •Having one of the following symptoms: Dry cough, severe weakness and fatigue, dyspnea, chest pain, fever greater than 38° C
- •Less than 3 days have passed since the first sign started
- •Definitive diagnosis of Covid-19 based on RT-PCR test or Involvement of a maximum of 3 or 4 pulmonary lobes with an area less than one third of the volume of each lobe or Infection of one or two lobes with a larger area in the patient's CT scan view
排除标准
- •Patient who has previously had COVID-19 or has been hospitalized for COVID-19
- •Participate in any other clinical trial for the treatment of COVID-19
- •Bradycardia, abnormal primary ECG
- •Active cancer, immunodeficiency or treatment with immunosuppressive drugs
- •Underlying liver and kidney disease
研究者
相似试验
进行中（未招募）
1 期
Evaluation of phage therapy for the treatment of Pseudomonas aeruginosa wound infections in burned patients (Phase I-II clinical trial)EUCTR2014-000714-65-BEPherecydes Pharma SA125
尚未招募
Unknown
A study on fever using therapeutics of fever by H C AlleCTRI/2024/03/063748Sarada Krishna Homoeopathic medical college
招募中
3 期
Efficacy of maggot therapy on Staphilococcus aureus and Pseudomonas aeruginosa in diabetic foot ulcersChronic ulcer of skin, not elsewhere classified.Chronic ulcer of skin NOSIRCT2016060328232N1Vice Chancellor of Research, Tehran University of Medical Sciences50
招募中
3 期
Efficacy of Maggot therapy on burning ulcersIRCT20170531034272N2Tehran University of Medical Sciences24
已完成
1 期
Phase I/II clinical trial of biologic therapy with intratumoral TG1042 (Adenovirus-Interferon-gamma) in patients with Advanced Cutaneous T-Cell Lymphomas (CTCL) - Mycosis Fungoides and other CTCL - and multilesional Cutaneous B-Cell Lymphomas (CBCL)C84C84.0C85.1Mature T/NK-cell lymphomasMycosis fungoidesB-cell lymphoma, unspecifiedDRKS00000219Transgene39